APOB and atherosclerosis: Re-analysis of our ACVD cohort confirms the strong association of FHR1 with atherosclerosis in ACVD patients, as FHR1 levels correlate significantly with total cholesterol, clinically marker non-HDL cholesterol, and ApoB100 levels in these patients.